Wave Life Sciences (WVE) Other financing activities (2015 - 2026)

Wave Life Sciences (WVE) has 12 years of Other financing activities data on file, last reported at $330000.0 in Q2 2026.

• Quarterly Other financing activities fell 44.44% year-over-year to $330000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $14.1 million (up 148.23% YoY) and the FY2025 annual result came in at $14.9 million, up 399.09% from the prior year.
• Other financing activities retreated to $330000.0 in Q2 2026, from $1.9 million in the prior quarter.
• In the past five years, Other financing activities ranged from a high of $14.2 million in Q2 2022 to a low of -$13.9 million in Q4 2022.
• A 5-year average of $1.4 million and a median of $429000.0 in 2023 frame the typical range for Other financing activities.
• Annual changes were most pronounced in 2022 — Other financing activities sank 123.53% — and 2024, when it soared 4210.66%.
• Tracing WVE's Other financing activities over 5 years: stood at -$13.9 million in 2022, then soared by 102.29% to $319000.0 in 2023, then sank by 3586.21% to -$11.1 million in 2024, then surged by 187.96% to $9.8 million in 2025, then slumped by 96.63% to $330000.0 in 2026.
• The last three Other financing activities figures came in at $330000.0 (Q2 2026), $1.9 million (Q1 2026), and $9.8 million (Q4 2025), per Business Quant data.